Contineum Therapeutics (CTNM) Net Margin (2023)
Contineum Therapeutics' Net Margin history spans 1 years, with the latest figure at 83.2% for Q2 2023.
- Quarterly Net Margin changed N/A to 83.2% in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 62.93% through Jun 2024, changed N/A year-over-year, with the annual reading at 45.44% for FY2023, N/A changed from the prior year.
- Net Margin came in at 83.2% for Q2 2023.
- In the past five years, Net Margin ranged from a high of 83.2% in Q2 2023 to a low of 83.2% in Q2 2023.